Of the CSC markers, BMI-1 and CD44 indicated a significantly worse prognosis on survival, while ALDH1 and BCL11B appear to have protective properties for HNSCC survival [20]. This evidence concerns the gene BCL11B and head and neck squamous cell carcinoma.